{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T05:47:24Z","timestamp":1776923244210,"version":"3.51.2"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82350003"],"award-info":[{"award-number":["82350003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.bioorg.2025.108770","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T23:06:42Z","timestamp":1752880002000},"page":"108770","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A novel CB2 agonist peptide with bone-promoting activity"],"prefix":"10.1016","volume":"163","author":[{"given":"Zhiheng","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zehua","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruoxi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junqi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaogang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bioorg.2025.108770_bb0005","doi-asserted-by":"crossref","first-page":"128","DOI":"10.22141\/pjs.13.3.2023.378","article-title":"Guideline for diagnostic, prevention and treatment of postmenopausal osteoporosis","volume":"13","author":"Grygorieva","year":"2023","journal-title":"PAIN, JOINTS, SPINE"},{"issue":"10","key":"10.1016\/j.bioorg.2025.108770_bb0010","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1007\/s00198-021-05900-y","article-title":"The clinician\u2019s guide to prevention and treatment of osteoporosis","volume":"33","author":"LeBoff","year":"2022","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bioorg.2025.108770_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108168","article-title":"Advances in pathogenesis and therapeutic strategies for osteoporosis","volume":"237","author":"Song","year":"2022","journal-title":"Pharmacol. Ther."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108770_bb0020","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S2213-8587(17)30188-2","article-title":"Osteoporosis treatment: recent developments and ongoing challenges","volume":"5","author":"Khosla","year":"2017","journal-title":"The lancet Diabetes & endocrinol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108770_bb0025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bone.2011.04.022","article-title":"Bisphosphonates: the first 40 years","volume":"49","author":"Russell","year":"2011","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108770_bb0030","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108770_bb0035","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1210\/en.2015-1726","article-title":"Binding selectivity of abaloparatide for PTH-type-1-receptor conformations and effects on downstream signaling","volume":"157","author":"Hattersley","year":"2016","journal-title":"Endocrinology"},{"issue":"6441","key":"10.1016\/j.bioorg.2025.108770_bb0040","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108770_bb0045","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1073\/pnas.0504187103","article-title":"Peripheral cannabinoid receptor, CB2, regulates bone mass","volume":"103","author":"Ofek","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bioorg.2025.108770_bb0050","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s11914-020-00607-1","article-title":"The cannabinoids effect on bone formation and bone healing","volume":"18","author":"Raphael-Mizrahi","year":"2020","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.bioorg.2025.108770_bb0055","first-page":"523","article-title":"High-throughput virtual screening (HTVS) of natural compounds and exploration of their biomolecular mechanisms: an in silico approach[M]\/\/new look to phytomedicine","author":"Dhasmana","year":"2019","journal-title":"Academic Press"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108770_bb0060","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/jbmr.228","article-title":"CB2 cannabinoid receptor targets mitogenic Gi protein\u2013cyclin D1 axis in osteoblasts","volume":"26","author":"Ofek","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bioorg.2025.108770_bb0065","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00439-009-0708-8","article-title":"The cannabinoid receptor type 2 (CNR2) gene is associated with hand bone strength phenotypes in an ethnically homogeneous family sample","volume":"126","author":"Karsak","year":"2009","journal-title":"Hum. Genet."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108770_bb0070","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.tips.2010.06.003","article-title":"Peptide drugs to target G protein-coupled receptors","volume":"31","author":"Bellmann-Sickert","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108770_bb0075","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drudis.2014.10.003","article-title":"Peptide therapeutics: current status and future directions","volume":"20","author":"Fosgerau","year":"2015","journal-title":"Drug Discov. Today"},{"issue":"5","key":"10.1016\/j.bioorg.2025.108770_bb0080","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.soard.2014.01.032","article-title":"Effects on GLP-1, PYY, and leptin by direct stimulation of terminal ileum and cecum in humans: implications for ileal transposition","volume":"10","author":"Buchwald","year":"2014","journal-title":"Surg. Obes. Relat. Dis."},{"key":"10.1016\/j.bioorg.2025.108770_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2014.00063","article-title":"Neuroactive peptides as putative mediators of antiepileptic ketogenic diets","volume":"5","author":"Giordano","year":"2014","journal-title":"Front. Neurol."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108770_bb0090","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.tube.2014.03.011","article-title":"Antimicrobial peptides and proteins in mycobacterial therapy: current status and future prospects","volume":"94","author":"Padhi","year":"2014","journal-title":"Tuberculosis"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108770_bb0095","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41392-022-00904-4","article-title":"Therapeutic peptides: current applications and future directions","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108770_bb0100","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.drudis.2021.01.022","article-title":"Converting peptides into drugs targeting intracellular protein\u2013protein interactions","volume":"26","author":"Philippe","year":"2021","journal-title":"Drug Discov. Today"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108770_bb0105","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.tips.2021.11.008","article-title":"Targeting intracellular protein-protein interactions with macrocyclic peptides","volume":"43","author":"Buyanova","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108770_bb0110","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/med.21862","article-title":"Haste makes waste: a critical review of docking-based virtual screening in drug repurposing for SARS-CoV-2 main protease (M-pro) inhibition","volume":"42","author":"Macip","year":"2022","journal-title":"Med. Res. Rev."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108770_bb0115","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/bioinformatics\/bty707","article-title":"admetSAR 2.0: web-service for prediction and optimization of chemical ADMET properties","volume":"35","author":"Yang","year":"2019","journal-title":"Bioinformatics"},{"issue":"20","key":"10.1016\/j.bioorg.2025.108770_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222011212","article-title":"New pyridone-based derivatives as cannabinoid receptor type 2 agonists","volume":"22","author":"Fa\u00fandez-Parraguez","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108770_bb0125","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.cell.2018.12.011","article-title":"Crystal structure of the human cannabinoid receptor CB2","volume":"176","author":"Li","year":"2019","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.bioorg.2025.108770_bb0130","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nprot.2016.051","article-title":"Computational protein-ligand docking and virtual drug screening with the AutoDock suite","volume":"11","author":"Forli","year":"2016","journal-title":"Nat. Protoc."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108770_bb0135","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108770_bb0140","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2025.108770_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106377","article-title":"Development of yin-Yang ligand for cannabinoid receptors","volume":"133","author":"Qiu","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108770_bb0150","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.65834","article-title":"Osteogenic growth peptide is a potent anti-inflammatory and bone preserving hormone via cannabinoid receptor type 2","volume":"11","author":"Raphael-Mizrahi","year":"2022","journal-title":"Elife"},{"issue":"11","key":"10.1016\/j.bioorg.2025.108770_bb0155","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/s41419-021-04313-3","article-title":"Activation of cannabinoid receptor 2 alleviates glucocorticoid-induced osteonecrosis of femoral head with osteogenesis and maintenance of blood supply","volume":"12","author":"Sun","year":"2021","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108770_bb0160","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s00018-024-05443-5","article-title":"MAGL blockade alleviates steroid-induced femoral head osteonecrosis by reprogramming BMSC fate in rat","volume":"81","author":"Yang","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108770_bb0165","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70709","article-title":"Cannabinoid receptor type 2 agonist, GW405833, reduced the impacts of MDA-MB-231 breast Cancer cells on bone cells","volume":"14","author":"Inson","year":"2025","journal-title":"Cancer Med."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825006509?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825006509?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T05:09:45Z","timestamp":1776920985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825006509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":33,"alternative-id":["S0045206825006509"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108770","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel CB2 agonist peptide with bone-promoting activity","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108770","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108770"}}